CoChat
Sign Up
Cited by 114Health Systems, Economic Evaluations, Quality of LifeMental Health Treatment and AccessTreatment of Major Depression

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Cost-Effectiveness of Cognitive–Behavioural Therapy and Drug Interventions for Major Depression

Vos, Theo, Corry, Justine, Haby, Michelle M., Carter, Rob, Andrews, Gavin·2005·Australian & New Zealand Journal of Psychiatry
DOI 10.1080/j.1440-1614.2005.01652.x
Open this paper in CoChat — free account

Abstract

Objective Antidepressant drugs and cognitive-behavioural therapy (CBT) are effective treatment options for depression and are recommended by clinical practice guidelines. As part of the Assessing Cost-effectiveness -- Mental Health project we evaluate the available evidence on costs and benefits of CBT and drugs in the episodic and maintenance treatment of major depression. Method The cost-effectiveness is modelled from a health-care perspective as the cost per disability-adjusted life year. Interventions are targeted at people with major depression who currently seek care but receive non-evidence based treatment. Uncertainty in model inputs is tested using Monte Carlo simulation methods. Results All interventions for major depression examined have a favourable incremental cost-effectiveness ratio under Australian health service conditions. Bibliotherapy, group CBT, individual CBT by a psychologist on a public salary and tricyclic antidepressants (TCAs) are very cost-effective treatment options falling below 10,000 Australian dollars per disability-adjusted life year (DALY) even when taking the upper limit of the uncertainty interval into account. Maintenance treatment with selective serotonin re-uptake inhibitors (SSRIs) is the most expensive option (ranging from 17,000 Australian dollars to 20,000 Australian dollars per DALY) but still well below 50,000 Australian dollars, which is considered the affordable threshold. Conclusions A range of cost-effective interventions for…

Overview

Integrity signals

Registry

Crossref · 10.1080/j.1440-1614.2005.01652.x

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Research works printed but not linked: 8

  1. Australian Bureau of Statistics. Mental health and wellbeing: profile of adults, Australia, 1997. Australian Bureau of Statistics, Canberra 1998.
  2. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry 2000; 157: 1–45.
  3. Geddes J R, Freemantle N, Mason J, Eccles M P, Boynton J. SSRIs versus other antidepressants for depressive disorder (Cochrane Review). The Cochrane library. Update Software, Oxford 2000, Issue 1.
  4. Barbui C, Hotopf M, Freemantle N, . Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence (Cochrane Review). The Cochrane library. Update Software, Oxford 2001, Issue 1.
  5. Britt H, Miller G, Charles J, . General practice activity in Australia 1999–00. Australian Institute of Health and Welfare (General Practice Series no. 5), Canberra 2000, AIHW Cat. No. GEP 5.
  6. 10.1037/0022-006X.66.4.685 · DOI · Paper page
  7. 10.1037/0022-006X.63.4.644 · DOI
  8. 10.1037/0022-006X.57.3.403 · DOI

Cited by

Sorted by citations

See all 114

Related

See all

Metadata

Authors
Vos, T., Corry, J., Haby, M. M., Carter, R., & Andrews, G.
Affiliations
  • The University of Queensland (AU)
  • UNSW Sydney (AU)
  • Department of Health and Human Services (AU)
  • The University of Melbourne (AU)
Corresponding author
Vos, Theo
ORCID
Venue
Australian & New Zealand Journal of Psychiatry
Publisher
SAGE Publications
Published
2005-08
Volume
39
Issue
8
Pages
683-692
ISSN
  • 0004-8674 (ISSN-L)
  • 1440-1614
DOI
10.1080/j.1440-1614.2005.01652.x
OpenAlex
W2135823835
Cited by
114
References
50
Citations by year
2026: 3 · 2025: 2 · 2024: 4 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 4 · 2014: 5 · 2013: 11 · 2012: 13
FWCI
16.30
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Australian & New Zealand Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
major depressive disorder, cost-effectiveness, cognitive behavioral therapy, antidepressants, maintenance therapy, selective serotonin reuptake inhibitors, tricyclic antidepressants, bibliotherapy, group cognitive behavioral therapy, disability-adjusted life years, health policy
MeSH terms
Antidepressive Agents, Australia, Cost-Benefit Analysis, Major Depressive Disorder, Humans, Mental Health Services, Cognitive Behavioral Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review